Alitretinoin Completed Phase 3 Trials for Atopic Dermatitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00519675Alitretinoin in the Treatment of Chronic Hand Eczema
NCT00817063Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema